Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Understanding anti-TNF treatment failure: does serum triiodothyronine-to-thyroxine (T3/T4) ratio predict therapeutic ou…
Lin S; Chanchlani N; Carbery I; Janjua M; Nice R; McDonald TJ; Bewshea C; Kennedy NA; Ahmad T; Selinger CP; Goodhand JR; PANTS consortium.
Aliment Pharmacol Ther
(Unknown)
Published: 2022
Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflo…
Visaggi P; Ghisa M; Del Corso G; Baiano Svizzero F; Mariani L; Tolone S; Frazzoni M; Buda A; Bellini M; Savarino V; Penagini R; Gyawali CP; Savarino EV; de Bortoli N.
Aliment Pharmacol Ther
(Unknown)
Published: 2022
Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real…
Atia O; Pujol-Muncunill G; Navas-López VM; Orlanski-Meyer E; Ledder O; Lev-Tzion R; Focht G; Shteyer E; Stein R; Aloi M; Russell RK; Martin-de-Carpi J; Turner D.
Aliment Pharmacol Ther
(Unknown)
Published: 2022
Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B: week 144 r…
Ogawa E; Nakamuta M; Koyanagi T; Ooho A; Furusyo N; Kajiwara E; Dohmen K; Kawano A; Satoh T; Takahashi K; Azuma K; Yamashita N; Yamashita N; Sugimoto R; Amagase H; Kuniyoshi M; Ichiki Y; Morita C; Kato M; Shimoda S; Nomura H; Hayashi J; Kyushu University Liver Disease Study (KULDS) Group.
Aliment Pharmacol Ther
(Unknown)
Published: 2022
A retrospective cohort study: pre-operative oral enteral nutritional optimisation for Crohn's disease in a UK tertiary …
Meade S; Patel KV; Luber RP; O'Hanlon D; Caracostea A; Pavlidis P; Honap S; Anandarajah C; Griffin N; Zeki S; Ray S; Mawdsley J; Samaan MA; Anderson SH; Darakhshan A; Adams K; Williams A; Sanderson JD; Lomer M; Irving PM.
Aliment Pharmacol Ther
(Unknown)
Published: 2022
Review article: vascular effects of PPARs in the context of NASH.
Aliment Pharmacol Ther
(Unknown)
Published: 2022
Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, scr…
Fehily SR; Al-Ani AH; Abdelmalak J; Rentch C; Zhang E; Denholm JT; Johnson D; Ng SC; Sharma V; Rubin DT; Gibson PR; Christensen B.
Aliment Pharmacol Ther
(Unknown)
Published: 2022
The knowledge and skills needed to perform intestinal ultrasound for inflammatory bowel diseases-an international Delph…
Madsen GR; Wilkens R; Boysen T; Burisch J; Bryant R; Carter D; Gecse K; Maaser C; Maconi G; Novak K; Palmela C; Nayahangan LJ; Tolsgaard MG.
Aliment Pharmacol Ther
(Unknown)
Published: 2022
Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal i…
Sulkowski M; Telep LE; Colombo M; Durand F; Reddy KR; Lawitz E; Bourlière M; Cheinquer N; Scherbakovsky S; Ni L; Force L; Ramroth H; Gaggar A; Chokkalingam AP; Sise ME.
Aliment Pharmacol Ther
(Unknown)
Published: 2022
Randomised clinical trial: a phase 1b study of GB004, an oral HIF-1α stabiliser, for treatment of ulcerative colitis.
Danese S; Levesque BG; Feagan BG; Jucov A; Bhandari BR; Pai RK; Taylor Meadows K; Kirby BJ; Bruey JM; Olson A; Osterhout R; Van Biene C; Ford J; Aranda R; Raghupathi K; Sandborn WJ.
Aliment Pharmacol Ther
(Unknown)
Published: 2022